About MattsonJack: Formed in 1986, The Mattson Jack Group, Inc. (MattsonJack), a Kantar Health company, is a global consulting firm devoted exclusively to the pharmaceutical and biotech industries.  We combine a strong commercial orientation with a scientific focus to provide innovative solutions to our clients’ business challenges in virtually every therapeutic area.  MattsonJack consultants have expertise in pricing and reimbursement, custom epidemiology, technology assessment, business and strategic plan development, due diligence and licensing support, market modeling and forecasting, and primary market research.  MattsonJack supports its clients’ interests through its custom consulting and multiclient offerings, including Epi Database®, Forecast Architect®, CancerNFluence®, Oncology Marketing Strategies U.S., Oncology Market Access Europe, and CancerMPact®. For more information, visit www.mattsonjack.com.